• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    9.46 Up 0.44(4.88%) 4:00PM EST
    |After Hours : 9.46 0.00 (0.00%) 4:38PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.02
    Open:9.19
    Bid:8.91 x 400
    Ask:9.85 x 2000
    1y Target Est:13.43
    Beta:1.97
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:9.16 - 10.00
    52wk Range:6.88 - 18.18
    Volume:5,017,039
    Avg Vol (3m):1,154,660
    Market Cap:1.17B
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HALO

    Comparison

    Symbol% ChgMkt Cap
    HALOUp 4.88%1.17B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.63
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback